"Caco-2 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.
| Descriptor ID |
D018938
|
| MeSH Number(s) |
A11.251.210.190.160 A11.251.860.180.160 A11.436.140
|
| Concept/Terms |
Caco-2 Cells- Caco-2 Cells
- Caco 2 Cells
- Caco-2 Cell
- Cell, Caco-2
- Cells, Caco-2
|
Below are MeSH descriptors whose meaning is more general than "Caco-2 Cells".
Below are MeSH descriptors whose meaning is more specific than "Caco-2 Cells".
This graph shows the total number of publications written about "Caco-2 Cells" by people in this website by year, and whether "Caco-2 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 28 | 28 |
| 2018 | 1 | 20 | 21 |
| 2019 | 0 | 8 | 8 |
| 2020 | 0 | 23 | 23 |
| 2021 | 0 | 24 | 24 |
To return to the timeline, click here.
Below are the most recent publications written about "Caco-2 Cells" by people in Profiles.
-
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021 09 01; 6(1):331.
-
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther. 2021 07 29; 6(1):288.
-
Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2. Biomolecules. 2021 07 28; 11(8).
-
Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs. Antimicrob Agents Chemother. 2021 09 17; 65(10):e0115521.
-
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication. Cell Rep. 2021 08 03; 36(5):109479.
-
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome. Cell Rep. 2021 08 03; 36(5):109482.
-
TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J. 2021 08 16; 40(16):e107821.
-
ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2. J Virol. 2021 07 12; 95(15):e0032721.
-
Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium. mBio. 2021 08 31; 12(4):e0085021.